Prognostic Significance of the Ki67 Scoring Categories in Breast Cancer Subgroups-Reference-Cited by-同舟云学术

Prognostic Significance of the Ki67 Scoring Categories in Breast Cancer Subgroups

Published:2014-10 Issue:5 Volume:14 Page:323-329.e3
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Niikura Naoki,Masuda Shinobu,Kumaki Nobue,Xiaoyan Tang,Terada Mizuho,Terao Mayako,Iwamoto Takayuki,Oshitanai Risa,Morioka Toru,Tuda Banri,Okamura Takuho,Saito Yuki,Suzuki Yasuhiro,Tokuda Yutaka

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference24 articles.

1. Proliferation marker Ki-67 in early breast cancer;Urruticoechea;J Clin Oncol,2005

2. Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients;de Azambuja;Br J Cancer,2007

3. Strategies for subtypes–dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011;Goldhirsch;Ann Oncol,2011

4. Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer Working Group;Dowsett;J Natl Cancer Inst,2011

5. Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health Recurrence Score in early breast cancer;Cuzick;J Clin Oncol,2011

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Survival Outcomes and Risk Factors for Axillary and Locoregional Recurrence in Japanese Patients with Sentinel Node-Positive Breast Cancer Treated in Accordance with the ACOSOG Z0011 Strategy;Oncology;2024-08-19

2. Risk factors for recurrence in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative early breast cancer in Japan: a systematic literature review and meta-analysis;Current Medical Research and Opinion;2024-04-10

3. Augmenting breast cancer diagnosis: Incorporating MRI for the assessment of major molecular subtypes;Indian Journal of Breast Imaging;2023-10-27

4. Evaluation of the international Ki67 working group cut point recommendations for early breast cancer: comparison with 21-gene assay results in a large integrated health care system;Breast Cancer Research and Treatment;2023-10-17

5. Validation of the PREDICT Prognostication Tool in US Patients With Breast Cancer;Journal of the National Comprehensive Cancer Network;2023-10